Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | C16orf88 |
| Upstream (Parents) |
|---|
| (<<) LOC729602///LOC642799///NPIPL3 → C16orf88 |
| (<<) CSPP1 → C16orf88 |
| (<<) LRRFIP1 → C16orf88 |
| (<<) TOP1 → C16orf88 |
| (<<) RSRC1 → C16orf88 |
| Downstream (Children) |
|---|
| C16orf88 → PCDH9 (>>) |
| C16orf88 → FLJ11292 (>>) |
| C16orf88 → PMS2L2 (>>) |
| C16orf88 → CDK5R1 (>>) |
| C16orf88 → PCDHA1///PCDHA2///PCDHA3///PCDHA4///PCDHA5///PCDHA6///PCDHA7///PCDHA8///PCDHA10///PCDHA11///PCDHA12///PCDHA13///PCDHAC1///PCDHAC2///PCDHA9 (>>) |
| C16orf88 → GRTP1 (>>) |
| C16orf88 → RABEP2 (>>) |
| C16orf88 → LOC100132773///LOC100131868///LOC100129064///PPP4R2 (>>) |
| C16orf88 → USP12 (>>) |
| C16orf88 → INSR (>>) |
| C16orf88 → CDC42EP3 (>>) |
| C16orf88 → LOR (>>) |
| C16orf88 → GDPD3 (>>) |
| C16orf88 → CSPP1 (>>) |
| C16orf88 → KAL1 (>>) |
| C16orf88 → PRSS23 (>>) |
| C16orf88 → METRN (>>) |
| C16orf88 → LRRFIP1 (>>) |
| C16orf88 → ITGAV (>>) |
| C16orf88 → OXCT1 (>>) |
| C16orf88 → RBM7 (>>) |
| C16orf88 → LSM12 (>>) |
